Gennex Laboratories Board of Directors

Get the latest insights into the leadership at Gennex Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dinesh Kumar KejriwalCompany Secretary & Compliance Officer
Arihant BaidManaging Director
Dilip Raj SinghviNon Executive Independent Director
A S Nageswar RaoNon Executive Independent Director
ARR PantuluNon Executive Director
Sandeep Kumar DagaNon Independent & Non Executive Director

Gennex Laboratories Share price

GENNEX

10.36

0.08 (0.78%)
Last updated on 24 Apr, 2026 | 15:59 IST
Today's High

10.48

Today's Low

10.15

52 Week Low

7.05

52 Week High

17.25

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Gennex Laboratories FAQs

The board at Gennex Laboratories consists of experienced professionals, including Dinesh Kumar Kejriwal, Arihant Baid, and others, overseeing the company’s strategic and corporate governance.

Directors at Gennex Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dinesh Kumar Kejriwal is the current chairman at Gennex Laboratories.

Executive directors at Gennex Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Gennex Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Gennex Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost